Martin Hoffmann

4PUBLICATIONS
15CO-AUTHORS
Molecular targetsPredictive and prognostic markersSystems biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Dec 05, 2025
Micrometastasis-derived models enable drug testing for early-stage, high-risk melanoma patients.

Kathrin Weidele, Christian Werno, Steffi Treitschke

|Oct 06, 2020
Interleukin-6 trans-signaling is a candidate mechanism to drive progression of human DCCs during clinical latency.

Melanie Werner-Klein, Ana Grujovic, Christoph Irlbeck

|Feb 11, 2018
Genetic alterations driving metastatic colony formation are acquired outside of the primary tumour in melanoma.

Melanie Werner-Klein, Sebastian Scheitler, Martin Hoffmann

Pageof 1